Ebola virus antibody decay–stimulation in a high proportion of survivors

Neutralizing antibody function provides a foundation for the efficacy of vaccines and therapies(1–3). Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection assay and a well-defined set of solid-phase assays, we describe a wide spectrum of antibody responses in a cohort of health...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Nature
Autori principali: Adaken, Charlene, Scott, Janet T., Sharma, Raman, Gopal, Robin, Dicks, Steven, Niazi, Saidia, Ijaz, Samreen, Edwards, Tansy, Smith, Catherine C., Cole, Christine P., Kamara, Philip, Kargbo, Osman, Doughty, Heidi A., van Griensven, Johan, Horby, Peter W., Gevao, Sahr M., Sahr, Foday, Dimelow, Richard J., Tedder, Richard S., Semple, Malcolm G., Paxton, William A., Pollakis, Georgios
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7839293/
https://ncbi.nlm.nih.gov/pubmed/33505020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41586-020-03146-y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi